Target intelligence / Profile preview

Tyrosine-protein kinase transforming protein Src (v-Src)

Target
v-Src
Molecular classification
Enzyme, Protein kinase, Tyrosine kinase, Non-receptor tyrosine kinase, Src family kinase (SFK)
01

Overview

Tyrosine-protein kinase v-Src is a viral oncoprotein encoded by the Rous sarcoma virus v-Src gene, distinguished from its cellular counterpart c-Src by the absence of a key inhibitory phosphorylation site (Tyr527). This loss results in constitutive (always-on) kinase activity, driving abnormal cell proliferation, altered cell morphology, loss of contact inhibition, increased invasiveness, and ultimately, tumor formation. Structurally, v-Src is composed of several domains: SH3, SH2, and a catalytic kinase domain, enabling it to phosphorylate tyrosine residues on numerous substrates that control signal transduction, growth, and survival. v-Src and the Src family kinases are central to normal and malignant cellular processes, making them critical subjects for anti-cancer drug development and molecular research.

Other names
v-SrcSrc oncogeneTyrosine-protein kinase SrcTransforming protein Src
02

Mechanism of action

Inhibition of kinase activity (competitive ATP binding at kinase domain) Suppression of downstream proliferative and motility signaling

03

Biological functions

Signal transductionCell proliferationCell motilityCell morphologyCytoskeletal reorganizationCell survivalMetabolism regulation (in cancer)
04

Disease associations

Cancer (role in sarcoma, many other cancers via transformation)TumorigenesisMetastasis
05

Safety considerations

Kinase inhibitor class toxicity (e.g., myelosuppression, cardiovascular risk)Off-target inhibitionRisk of immune system modulation and impaired wound healing
06

Interacting drugs

PP2 (Src-selective inhibitor)

3 more in the full profile.

07

Biomarkers

Elevated phospho-Src (activation state marker)High Src kinase activity in tumor samples (indicator of malignant transformation and therapeutic sensitivity)

Beyond the preview

Go deeper on Tyrosine-protein kinase transforming protein Src (v-Src).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein kinase transforming protein Src (v-Src).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call